The Mirage Hotel Las Vegas, NV March 31 – April 2 2014 Conference home page We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems. From the 2013 event: This year’s event…
Blog Archives
PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by…
PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess…
Tagged with: brady kinesia, company, dbs, deep brain stimulation, development, funding, growth, homeview, parkinson's disease, pd, pharmaceutical, stroke, symptom response, telemedicine, therapy, treatment, tremor, updrs
PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine
VIEW PRESS RELEASE [PDF] 13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress…
Tagged with: clinical trial, clinical trials, company, dbs, deep brain stimulation, development, efficacy, growth, homeview, mds, motion sensor, parkinson's disease, pd, tablet, technology, telemedicine, web app
PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of…